- Home
- CRNX vs INDV Comparison
CRNX vs INDV Comparison
Compare CRNX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | INDV |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRNX | INDV |
|---|---|---|
| Price | $47.18 | $35.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $71.00 | $32.50 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $1,535,000.00 | ★ $1,180,000,000.00 |
| Revenue This Year | $425.31 | $1.09 |
| Revenue Next Year | $943.50 | N/A |
| P/E Ratio | ★ N/A | $35.79 |
| Revenue Growth | ★ 47.74 | N/A |
| 52 Week Low | $24.10 | $7.62 |
| 52 Week High | $60.34 | $35.31 |
Technical Indicators
Market Signals| Indicator | CRNX | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 78.45 |
| Support Level | $44.52 | $33.50 |
| Resistance Level | $48.62 | $33.64 |
| Average True Range (ATR) | 2.00 | 1.12 |
| MACD | 0.29 | 0.01 |
| Stochastic Oscillator | 72.38 | 96.36 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.